The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients

Dermatology

Volumn 215, Issue 4, 2007, Pages 348-351

  Nijsten, Tamar ^a   Sampogna, Francesca ^b   Stern, Robert S ^c   Abeni, Damiano ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Health related quality of life; Impact of Psoriasis Questionnaire; Psoriasis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; CULTURAL FACTOR; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RASCH ANALYSIS;

ACTIVITIES OF DAILY LIVING; ADULT; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34948830139     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107629     Document Type: Article

References (16)

1. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE: Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 1998;23:391-398.
2. Sampogna F, Sera F, Abeni D;IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators: Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004;122:602-607.
3. McKenna KE, Stern RS: The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997;36:388-394.
4. Nijsten T, Unaeze J, Stern RS: Refinement and reduction of the Impact of Psoriasis Questionnaire: Classical Test Theory vs. Rasch analysis. Br J Dermatol 2006;154:692-700.
5. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ: Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-1440.
6. Fleischer AB Jr, Feldman SR, Rapp SR, et al: Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol 1996;107:26-29.
7. Rasch G: Probabilistic Models for Some Intelligence and Attainment Tests. Chicago, University of Chicago Press, 1960.
8. Tennant A, McKenna SP, Hagell P: Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004;7:S22-S26.
9. Nijsten T, Meads D, de Korte J, Sampogna F, Gelfand JM, Ongenae K, Evers A, Augustin M: Cross-cultural inequivalence in dermatology-specific health-related quality of life instruments among psoriasis patients. J Invest Dermatol, Epub ahead of print.
10. Sampogna F, Tabolli S, Mastroeni S, Di Pietro C, Fortes C, Abeni D: Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007;215:341-347.
11. Gupta MA, Gupta AK: Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995;34:700-703.
12. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE: Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-76.
13. Naldi L: Health-related quality of life: from health economics to bedside? Dermatology 2007;215:273-276.
14. Nijsten T, Whalley D, Gelfand J, et al: The psychometric properties of the Psoriasis Disability Index in United States patients. J Invest Dermatol 2005;125:665-672.
15. Nijsten T, Meads DM, McKenna SP: Dimensionality of the Dermatology Life Quality Index (DLQI): a commentary. Acta Derm Venereol 2006;86:284-285.
16. Nijsten T, Sampogna F, Chren MM, Abeni D: Rasch analysis to test and shorten the Skindex-29: Skindex-17. J Invest Dermatol 2006 126:1244-1250.